SMTL ID : 7mfg.1

Cryo-EM structure of the VRC310 clinical trial, vaccine-elicited, human antibody 310-030-1D06 Fab in complex with an H1 NC99 HA trimer

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-3-3-3-3-mer

Ligands

3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA.1: 7 residues within 4Å: Chain B: N.146, E.147, E.150, S.151, N.154, T.156 Chain D: F.68 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.2: 7 residues within 4Å: Chain F: N.146, E.147, E.150, S.151, N.154, T.156 Chain H: F.68 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.3: 7 residues within 4Å: Chain J: N.146, E.147, E.150, S.151, N.154, T.156 Chain L: F.68 No protein-ligand interaction detected (PLIP)

21 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.4: 1 residues within 4Å: Chain A: N.11 Ligand excluded by PLIP NAG.5: 1 residues within 4Å: Chain A: N.54 Ligand excluded by PLIP NAG.6: 1 residues within 4Å: Chain A: N.125 Ligand excluded by PLIP NAG.7: 4 residues within 4Å: Chain A: E.86, N.87, S.134, R.220 Ligand excluded by PLIP NAG.8: 1 residues within 4Å: Chain A: N.23 Ligand excluded by PLIP NAG.9: 3 residues within 4Å: Chain A: D.275, K.277, N.286 Ligand excluded by PLIP NAG.10: 1 residues within 4Å: Chain A: N.159 Ligand excluded by PLIP NAG.11: 1 residues within 4Å: Chain E: N.11 Ligand excluded by PLIP NAG.12: 1 residues within 4Å: Chain E: N.54 Ligand excluded by PLIP NAG.13: 1 residues within 4Å: Chain E: N.125 Ligand excluded by PLIP NAG.14: 4 residues within 4Å: Chain E: E.86, N.87, S.134, R.220 Ligand excluded by PLIP NAG.15: 1 residues within 4Å: Chain E: N.23 Ligand excluded by PLIP NAG.16: 3 residues within 4Å: Chain E: D.275, K.277, N.286 Ligand excluded by PLIP NAG.17: 1 residues within 4Å: Chain E: N.159 Ligand excluded by PLIP NAG.18: 1 residues within 4Å: Chain I: N.11 Ligand excluded by PLIP NAG.19: 1 residues within 4Å: Chain I: N.54 Ligand excluded by PLIP NAG.20: 1 residues within 4Å: Chain I: N.125 Ligand excluded by PLIP NAG.21: 4 residues within 4Å: Chain I: E.86, N.87, S.134, R.220 Ligand excluded by PLIP NAG.22: 1 residues within 4Å: Chain I: N.23 Ligand excluded by PLIP NAG.23: 3 residues within 4Å: Chain I: D.275, K.277, N.286 Ligand excluded by PLIP NAG.24: 1 residues within 4Å: Chain I: N.159 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Andrews, S.F. et al., A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination. Nat Med (2022)

Release Date

2021-11-03

Peptides

Hemagglutinin HA1 chain: AEI
Hemagglutinin HA2 chain: BFJ
310-030-1D06 Heavy: CGK
310-030-1D06 Light: DHL

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

E
C

I
G

B
B

F
D

J
I

C
H

G
E

K
J

D
L

H
F

L
K

Hemagglutinin HA1 chain

Hemagglutinin HA2 chain

310-030-1D06 Heavy

310-030-1D06 Light

Related Entries With Identical Sequence